By Professor David Lawson Morris

Journal articles

Kozman DR; Thornton MJ; Lubowski DZ; Morris DL; King DW, 2003, 'HEPATIC METASTASIS FROM COLORECTAL CANCER: AN ANALYSIS OF MORBIDITY AND MORTALITY OF METACHRONOUS AND SYNCHRONOUS TREATMENT', American Journal of Gastroenterology, 98, pp. S99 - S99, http://dx.doi.org/10.1111/j.1572-0241.2003.08027.x

Kariappa S; Links MJ; Morris DL, 2003, 'Non-Surgical treatment options in hepatocellular carcinoma', Cancer Reviews Asia - Pacific, 1, pp. 245 - 279

Steinke K; Glenn DW; King J; Morris DL, 2003, 'Percutaneous pulmonary radiofrequency ablation: difficulty achieving complete ablations in big lung lesions', British Journal of Radiology, 76, pp. 742 - 745

Steinke K; King J; Glenn DW; Morris DL, 2003, 'Percutaneous radiofrequency of lung tumors: Difficulty withdrawing the hooks resulting in a split needle', Cardiovascular and Interventional Radiology, 26, pp. 583 - 585

Steinke K; King J; Glenn DW; Morris DL, 2003, 'Pulmonary hemorrhage during percutaneous radiofrequency ablation: a more frequent complication than assumed?', Interactive Cardiovascular and Thoracic Surgery, 2, pp. 462 - 465

Steinke K; King J; Glenn DW; Morris DL, 2003, 'Radiologic appearance and complications of percutaneous computed tomography- Guided radiofrequency-Ablated pulmonary metastases from colorectal carcinoma', Journal of Computer Assisted Tomography, 27, pp. 750 - 757

King J; Zhao J; Clingan PR; Morris DL, 2003, 'Randomised double blind placebo control study of adjuvant treatment with the metalloproteinase inhibitor, marimastat in patients with inoperable colorectal hepatic metastases: Significant survival advantage in patients with musculoskeletal side-effec', Anticancer Research, 23, pp. 639 - 646

Steinke K; Arnold C; Wulf S; Morris DL, 2003, 'Safety of radiofrequency ablation of myocardium and lung adjacent to the heart: An animal study', Journal of Surgical Research, 114, pp. 140 - 145

May LA; Huang Q; Morris D; Danis V; Manolios N, 2002, 'Relationship of tumour necrosis factor alpha gene polymorphisms and neuropsychiatric lupus', LUPUS, 11, pp. 114 - 118, http://dx.doi.org/10.1191/0961203302lu151oa

King J; Caplehorn JR; Seifert J; Preketes AO; Clingan PR; Morris DL, 2002, 'A Randomised Placebo Control Double-blind trial of Ranitidine in Patients with Colorectal Hepatic Metastases: Survival Advantage in Patients with Poor Cell Mediated Immunity', Gastrointestinal Oncology, 4, pp. 39 - 44

Hewitt PM; Armstrong N; Bowrey P; Cherian M; Morris DL, 2002, 'Cimetidine prevents suppression of delayed hypersensitivity in an animal model of hemorrhagic shock', Injury - International Journal of the Care of the Injured, 33, pp. 673 - 678

Gruenberger T; King J; Chung TT; Clingan PR; Morris DL, 2002, 'Echogenicity of Liver Metastases from Colorectal Carcinoma Is an Independent prognostic Factor in Patients Treated with Regional Chemotherapy', Cancer, 94, pp. 1753 - 1759

Talbot ML; Clark JR; Clingan PR; Morris DL, 2002, 'Gastroduodenal ulceration following hepatic arterial chemotherapy: the role of methylene blue endoscopy in the investigation of pain', HPB, 4, pp. 29 - 34

Morris DL; Jourdan JL; Finlay I; Gruenberger T; The MP; Pourgholami MH, 2002, 'Hepatic intra-arterial injection of 1,25-dihydroxyvitamin D3 in lipiodol: Pilot study in patients with hepatocellular cacinoma', International Journal of Oncology, 21, pp. 901 - 906

Seifert JK; France MP; Zhao J; Bolton E; Finlay I; Junginer T; Morris DL, 2002, 'Large volume hepatic freezing: Association with significant release of the cytokines interleukin-6 and tumor necrosis factor alpha in a rat model', World Journal of Surgery, 26, pp. 1333 - 1341

Gananadha S; Morris DL, 2002, 'Radiofrequency Ablation of Liver Malignancies', Gastrointestinal Oncology, 4, pp. 49 - 58

Gruenberger T; Morris DL, 2002, 'Stage treatment of bilobar hepatic metastases from colorectal cancer', European Journal of Surgery, 168, pp. 516 - 518

Morris DL, 2002, 'Surgery for liver metastases: How many?', Australian and New Zealand Journal of Surgery, 72, pp. 2 - 2

Terrett D; Lu Y; Bowrey P; Bolton EJ; Morris DL, 2001, 'Cimetidine increases lymphocyte infiltration alters cytokine gene expression in a murine colorectal cancer model', GI Cancer, 3, pp. 407 - 418

Morris DL; Jourdan JL; Pourgholami MH, 2001, 'Pilot study of albendazole in patients with advanced malignancy: Effect on serum tumor markers/high incidence of neutropenia', Oncology, 61, pp. 42 - 46, http://dx.doi.org/10.1159/000055351

Akhter J; Lu Y; Finlay I; Pourgholami MH; Morris DL, 2001, '1α,25-dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HEPG2', ANZ Journal of Surgery, 71, pp. 414 - 417, http://dx.doi.org/10.1046/j.1440-1622.2001.02147.x

Akhter J; Lu Y; Finlay I; Pourgholami MH; Morris DL, 2001, '1alpha,25-Dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HepG2', Australian and New Zealand Journal of Surgery, pp. 414 - 417

Finlay I; Stewart GJ; Akhter J; Morris DL, 2001, 'A phase one study of the hepatic arterial administration of 1,25-dihydroxyvitamin D3 for liver cancers', Journal of Gastroenterology and Hepatology, 16, pp. 333 - 337

Sidhu S; Magarey CJ; King J; Schwartz P; Morris DL, 2001, 'Adjuvant cimetidine in breast carcinoma: A prospective randomised control trial', Asian Journal of Surgery, pp. 161 - 163

Teoh W; Haghighi K; Morris DL, 2001, 'Aggressive multimodality treatment for primary malignant peritoneal mesothelioma', Australian and New Zealand Journal of Surgery, pp. 683 - 685

Finlay I; Stewart GJ; Shirley P; Woolfe S; Pourgholami MH; Morris DL, 2001, 'Hepatic arterial and intravenous administration of 1,25 dihydroxyvitamin D3 - evidence of a clinically significant hepatic first-pass effect', Cancer Chemotherapy and Pharmacology, pp. 209 - 214

Finlay I; Stewart GJ; Akhter J; Morris DL, 2001, 'Hepatocellular Carcinoma Treatment and Recurrence Marker. A Phase one study of the hepatic arterial administration of 1,25 dihydroxyvitamin D3 for liver cancers', Journal of Gastroenterology and Hepatology, 16, pp. 333 - 337

Pourgholami MH; Woon LA; Almajd R; Akhter J; Bowrey P; Morris DL, 2001, 'In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole', Cancer Letters, 165, pp. 43 - 49

Nye E; Butler P; Clingan P; Morris DL, 2001, 'Lipiodol avid liver metastases from adrenocortical carcinoma; Prospects for therapy?', Anticancer Research, 21, pp. 1445 - 1448

Boyle RA; Hewitt PM; Morris DL, 2001, 'lipiodol avidity of Hepatic Breast carcinoma metastases', Anticancer Research, pp. 3725 - 3728

Morris DL; Jourdan J; Pourgholami MH, 2001, 'Pilot study of albendazole in patients with advanced malignancy', Oncology, pp. 42 - 46

Gruenberger T; Jourdan J; Zhao J; King J; Morris DL, 2001, 'Reduction in Recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases', Arzneimittel - Forschung - Drug Research, 136, pp. 1154 - 1157

Harrison JD; Steele RJ; Morris DL; Hardcastle JD, 2001, 'Screening for gastric cancer: Endoscopic investigation of dyspeptic subjects identified by postal questionnaire', GI Cancer An International Journal, pp. 335 - 342

Ho C; Shumack SP; Morris DL, 2001, 'Subacute cutaneous lupus erythematosus associated with hepatocellular carcinoma', Australasian Journal of Dermatology, pp. 110 - 113

Butler P; Morris DL; King J; Mckay E; Parkes SL; Ring MT, 2001, 'Survival in patients with hepatocellular carcinoma treated with intra-arterial I-131 labelled lipiodol', GI Cancer An International Journal, pp. 359 - 369

King J; Gebski V; Morris DL, 2000, 'Relationship between quality of life (QoL) and a biological marker of outcome in patients with liver cancer.', PSYCHO-ONCOLOGY, 9, pp. S57 - S57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089846700227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Filice C; Brunetti E; Bruno R; Crippa FG; Vuitton D; Schantz P; Caremani M; Giorgio A; Bastid C; Stefaniak J; Zeyhle E; Wen H; Pelaez V; Pettinari R; Akhan O; Men S; Hernandez G; Schipper H; Morris DL, 2000, 'Percutaneous drainage of echinococcal cysts (PAIR - puncture, aspiration, injection, reaspiration): Results of a worldwide survey for assessment of its safety and efficacy [7] (multiple letters)', Gut, 47, pp. 156 - 157, http://dx.doi.org/10.1136/gut.47.1.156

Morris DL, 2000, 'Percutaneous drainage of echinococcal cysts (PAIR-puncture, aspiration, injection, reaspiration): results of a worldwide survey for assessment of its safety end efficacy - Reply', GUT, 47, pp. 157 - 157, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000087935500038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Finlay IG; Stewart GJ; Pourgholami MH; Akhter J; Morris DL, 2000, 'Lipid delivery agents for 1,25-dihydroxyvitamin D3 administration - A new treatment for hepatoma?', GUT, 46, pp. A72 - A72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000086170200287&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Finlay IG; Seifert JK; Stewart GJ; Morris DL, 2000, 'Erratum: Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection alone (European Journal of Surgical Oncology (2000) 26:3 (199-202))', European Journal of Surgical Oncology, 26, pp. 524 - 525, http://dx.doi.org/10.1053/ejso.2000.0939

Morris DL, 2000, 'Symposium on unresectable or advanced liver cancer', Asian Journal of Surgery, 23, pp. 1 - 2, http://dx.doi.org/10.1007/s101160050001

Pourgholami MH; Akhter J; Finlay I; Morris DL, 2000, '1,25 dihydroxyvitamin D3 dissolved in lipiodol produces a sustained antiproliferate effect in the human hepatoblastoma cell line hepG2.', Anticancer Research, 20, pp. 723 - 728

Bagia S; Hewitt PM; Morris DL, 2000, 'Anabolic steroid-induced hapatic adenomas with spontaneous haemorrhage in a bodybuider.', Australian and New Zealand Journal of Surgery, pp. 686 - 687

Johnston MB; Gal M; Lobo C; Perret N; Morris DL; Zou J; Cockayne DJ; Leon R, 2000, 'Carrier capture and relaxation in Stranski-Krastanow InxGa1-xAs/GaAs(311)B quantum dots', Physical Review - Section B - Condensed Matter, pp. 2737 - 2742

Jourdan J; Morris DL, 2000, 'Cryotherapy for unresectable liver cancers.', Asian Journal of Surgery, pp. 16 - 21

Gruenberger T; Jourdan J; Zhao J; King J; Morris DL, 2000, 'Echogenicity of liver metastases is an independent prognostic factor after curative treatment.', Archives of Surgery, 135, pp. 1285 - 1290

North H; King J; Morris DL, 2000, 'Effect of Marimastat on serum tumour markers in patients with colorectal cancer.', International Journal of Surgical Investigation, 2, pp. 213 - 217

Bolton E; King J; Morris DL, 2000, 'H2-antagonists in the treatment of colon and breast cancer.', Seminars in Cancer Biology, 10, pp. 3 - 10

Morris DL; Fox BJ; Luo J; Monamy V, 2000, 'Habitat-dependent competition and the co-existence of Australian heathland rodents', Oikos, pp. 294 - 306

Jourdan J; Akhter J; Bowrey P; Pourgholami MH; Morris DL, 2000, 'Hepatic intra-arterial injection of lipiodol- 1,25-dihydroxyvitamine D3 for hepatcellular carcinoma in rats.', Anticancer Research, 20, pp. 2739 - 2744

Back to profile page